Logo for Vitargent

Meet an Unreasonable Venture


Award-winning biotechnology company enabling manufacturers to more ethically ensure their products are safe from harmful chemicals.

Photo of Jimmy Tao

Jimmy Tao

CEO at Vitargent

More about Jimmy »
Employees 51–100
Headquarters Hong Kong
There are over 100,000 commercially available chemicals, but little is known about the effects many of those chemicals have on people. Vitargent is a biotechnology company that is pioneering the field of safety testing technology to make animal testing a thing of the past. By using medaka and zebrafish embryos to perform toxicity tests, Vitargent's solution is more comprehensive than chemical testing and more ethical than animal testing. They test at checkpoints along the supply chain, ensuring quality control at every stage of the production process. Clients include global cosmetics and skincare companies, food and beverage conglomerates, leading testing laboratories, and governments. Vitargent is the only ISO17025 accredited laboratory in Asia that provides fish embryo-based toxicity testing.

Notable Achievements

  • Investors include PwC, G.E.M. (China's Taylor Swift)
  • Owner of the world's largest biotoxicity & efficacy database on FMCGs
  • Company with deep technologies recognized as one of the Technology Pioneers by World Economic Forum

Currently Operating in Seven Regions

Press Mentions

June 29, 2018

PwC Hong Kong signs investment agreement with biotech and internet platform company Vitargent

Read on Cision »

February 2, 2018

Vitargent and PwC to accelerate product safety testing technologies

Read on foodqualitynews.com »

More Ventures in Health

Get the Unreasonable Newsletter

Get monthly updates on Vitargent and over 406 other ventures working to solve the world's toughest problems.

Read our Privacy Policy.